COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION

THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	KARL M. GELOTTE
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A CITRATE BUFFER EFFECTIVE TO PROVIDE A PH OF BETWEEN ABOUT 5 AND 7; AND C)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A TONICITY ADJUSTING AGENT EFFECTIVE TO MAKE THE FORMULATION SUBSTANTIALLY ISOTONIC WITH THE OSMOTIC PRESSURE OF THE BIOLOGICAL SYSTEM OF THE PATIENT.